{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:56:56Z","timestamp":1786985816767,"version":"build-2736575974"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cca.2026.121072","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:46:59Z","timestamp":1778546819000},"page":"121072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Inflammation and cardiovascular risk in autoimmune diseases: Mechanisms, biomarkers, and clinical implications"],"prefix":"10.1016","volume":"590","author":[{"given":"Enas","family":"Daoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobur","family":"Abduvoyitov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuktash","family":"Kurbonov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadyh Abdul","family":"Alhady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina Dawood","family":"Suleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajashree","family":"Panigrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin Kumar","family":"Tailor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.cca.2026.121072_bb0005","article-title":"Cardiovascular risk in autoimmune diseases: mechanisms, management, and emerging evidence","volume":"17","author":"Baloch","year":"2025","journal-title":"Cureus"},{"issue":"11","key":"10.1016\/j.cca.2026.121072_bb0010","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41569-024-01045-7","article-title":"Autoimmune diseases and atherosclerotic cardiovascular disease","volume":"21","author":"Porsch","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"issue":"4","key":"10.1016\/j.cca.2026.121072_bb0015","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s13668-024-00563-7","article-title":"Managing cardiovascular risk in patients with autoimmune diseases: insights from a nutritional perspective","volume":"13","author":"Chen","year":"2024","journal-title":"Curr. Nutr. Rep."},{"issue":"1\u20132","key":"10.1016\/j.cca.2026.121072_bb0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/prca.201400125","article-title":"Biomarkers for cardiovascular risk assessment in autoimmune diseases","volume":"9","author":"Teixeira","year":"2015","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.cca.2026.121072_bb0025","article-title":"Systematic review and meta-analysis of cardiovascular associated biomarkers in adults with asymptomatic autoimmune diseases","volume":"12","author":"Hong","year":"2025","journal-title":"Front. Cardiovasc. Med."},{"issue":"2","key":"10.1016\/j.cca.2026.121072_bb0030","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/prca.200800147","article-title":"Novel biomarkers of atherosclerosis and cardiovascular risk in autoimmune diseases: genomics and proteomics approaches","volume":"3","author":"L\u00f3pez-Pedrera","year":"2009","journal-title":"Proteomics Clin. Appl."},{"issue":"6","key":"10.1016\/j.cca.2026.121072_bb0035","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1191\/0961203303lu412oa","article-title":"TNF-\u03b1: a link between hypertriglyceridemia and inflammation in SLE patients with cardiovascular disease","volume":"12","author":"Svenungsson","year":"2003","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.cca.2026.121072_bb0040","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.autrev.2018.01.021","article-title":"Inflammation and atherosclerosis: cardiovascular evaluation in patients with autoimmune diseases","volume":"17","author":"Esc\u00e1rcega","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.cca.2026.121072_bb0045","doi-asserted-by":"crossref","DOI":"10.32604\/biocell.2025.072337","article-title":"Molecular and cellular mechanisms of neutrophil extracellular traps in cardiovascular diseases: from NET formation to mechanistic therapeutic targeting","volume":"50","author":"Dinc","year":"2026","journal-title":"Biocell"},{"issue":"19","key":"10.1016\/j.cca.2026.121072_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/cells14191562","article-title":"The role of neutrophil extracellular networks in cardiovascular pathology","volume":"14","author":"Szyma\u0144ska","year":"2025","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.cca.2026.121072_bb0055","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.bbrc.2018.07.069","article-title":"Citrullinated histone 3 causes endothelial barrier dysfunction","volume":"503","author":"Meegan","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.cca.2026.121072_bb0060","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.3390\/ijms23105626","article-title":"Endothelial dysfunction induced by extracellular neutrophil traps plays important role in the occurrence and treatment of extracellular neutrophil traps-related disease","volume":"23","author":"Yu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2026.121072_bb0065","doi-asserted-by":"crossref","first-page":"103141","DOI":"10.1016\/j.arr.2026.103141","article-title":"Multifaceted Cell Death in Atherosclerosis: Mechanisms, Pathological Impact, and Therapeutic Targeting","volume":"19","author":"Mu","year":"2026","journal-title":"Ageing Research Reviews"},{"issue":"3","key":"10.1016\/j.cca.2026.121072_bb0070","article-title":"Endothelial dysfunction: redox imbalance, NLRP3 inflammasome, and inflammatory responses in cardiovascular diseases","volume":"14","author":"Penna","year":"2025","journal-title":"Antioxidants (Basel)."},{"issue":"1","key":"10.1016\/j.cca.2026.121072_bb0075","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12959-022-00384-0","article-title":"Complement C5a induces the generation of neutrophil extracellular traps by inhibiting mitochondrial STAT3 to promote the development of arterial thrombosis","volume":"20","author":"Chen","year":"2022","journal-title":"Thromb. J."},{"issue":"10","key":"10.1016\/j.cca.2026.121072_bb0080","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/j.ekir.2021.08.005","article-title":"Long-term renal survival in antineutrophil cytoplasmic antibody\u2013associated glomerulonephritis with complement C3 deposition","volume":"6","author":"Oba","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.cca.2026.121072_bb0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/1756-185X.13370","article-title":"Vasculitis research: current trends and future perspectives","volume":"22","author":"Misra","year":"2019","journal-title":"Int. J. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.cca.2026.121072_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/biom15111586","article-title":"The type I interferon axis in systemic autoimmune diseases: from molecular pathways to targeted therapy","volume":"15","author":"Ishihara","year":"2025","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.cca.2026.121072_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037000","article-title":"Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients","volume":"7","author":"Somers","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2026.121072_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1277267","article-title":"Type I interferons induce endothelial destabilization in systemic lupus erythematosus in a Tie2-dependent manner","volume":"14","author":"Rafael-Vidal","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cca.2026.121072_bb0105","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/art.41518","article-title":"Modulation of cardiometabolic disease markers by type I interferon inhibition in systemic lupus erythematosus","volume":"73","author":"Casey","year":"2021","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.cca.2026.121072_bb0110","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/oxfordjournals.eurheartj.a015230","article-title":"Circulating cardiac-specific autoantibodies as markers of autoimmunity in clinical and biopsy-proven myocarditis","volume":"18","author":"Caforio","year":"1997","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.cca.2026.121072_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112476","article-title":"Serum anti-heart and anti-intercalated disk autoantibodies: novel autoimmune markers in cardiac sarcoidosis","volume":"10","author":"Caforio","year":"2021","journal-title":"J. Clin. Med."},{"issue":"23","key":"10.1016\/j.cca.2026.121072_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12237214","article-title":"Biomarkers in acute myocarditis and chronic inflammatory cardiomyopathy: an updated review of the literature","volume":"12","author":"Crisci","year":"2023","journal-title":"J. Clin. Med."},{"issue":"10354","key":"10.1016\/j.cca.2026.121072_bb0125","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(22)01349-6","article-title":"Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK","volume":"400","author":"Conrad","year":"2022","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.cca.2026.121072_bb0130","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.jacc.2024.04.030","article-title":"Association of autoimmune diseases with coronary atherosclerosis severity and ischemic events","volume":"83","author":"Mortensen","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.cca.2026.121072_bb0135","first-page":"2167","article-title":"Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"33","author":"Han","year":"2006","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.cca.2026.121072_bb0140","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13075-017-1315-z","article-title":"Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study","volume":"19","author":"Bengtsson","year":"2017","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.cca.2026.121072_bb0145","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/M14-2470","article-title":"Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study","volume":"163","author":"Haroon","year":"2015","journal-title":"Ann. Intern. Med."},{"issue":"22","key":"10.1016\/j.cca.2026.121072_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11226812","article-title":"Associations between cardiovascular outcomes and rheumatoid arthritis: a nationwide population-based cohort study","volume":"11","author":"Kang","year":"2022","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.cca.2026.121072_bb0155","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1016\/j.ijcard.2013.07.233","article-title":"Rheumatoid arthritis and risk of acute myocardial infarction\u2014a nationwide retrospective cohort study","volume":"168","author":"Chung","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"20","key":"10.1016\/j.cca.2026.121072_bb0160","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/heartjnl-2019-316193","article-title":"Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study","volume":"106","author":"Nikiphorou","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.cca.2026.121072_bb0165","article-title":"Rheumatoid arthritis and cardiovascular risk: retrospective matched-cohort analysis based on the RECORD study of the Italian Society for Rheumatology","volume":"8","author":"Argnani","year":"2021","journal-title":"Front Med. (Lausanne)."},{"key":"10.1016\/j.cca.2026.121072_bb0170","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejim.2021.10.001","article-title":"Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: data from the cardiovascular obesity and rheumatic DISease (CORDIS) study group","volume":"96","author":"Cacciapaglia","year":"2022","journal-title":"Eur. J. Intern. Med."},{"issue":"11","key":"10.1016\/j.cca.2026.121072_bb0175","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/art.42928","article-title":"Association of cardiovascular outcomes with low-dose glucocorticoid prescription in patients with rheumatoid arthritis","volume":"76","author":"Coburn","year":"2024","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.cca.2026.121072_bb0180","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/acr.23018","article-title":"Risk of myocardial infarction and stroke in newly diagnosed systemic lupus erythematosus: a general population-based study","volume":"69","author":"Avi\u00f1a-Zubieta","year":"2017","journal-title":"Arthritis Care Res."},{"issue":"5","key":"10.1016\/j.cca.2026.121072_bb0185","first-page":"709","article-title":"The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study","volume":"56","author":"Hermansen","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.cca.2026.121072_bb0190","article-title":"Increased cardiovascular risk in Korean patients with systemic lupus erythematosus: a population-based cohort study","volume":"14","author":"Han","year":"2024","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.cca.2026.121072_bb0195","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/art.43097","article-title":"Atherosclerotic plaque progression and incident cardiovascular events in a 10-year prospective study of patients with systemic lupus erythematosus: the impact of persistent cardiovascular risk factor target attainment and sustained DORIS remission","volume":"77","author":"Papazoglou","year":"2025","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.cca.2026.121072_bb0200","doi-asserted-by":"crossref","DOI":"10.1111\/exd.15010","article-title":"Prospective evaluation of cardiovascular risk and mortality in patients with psoriasis: an American population-based study","volume":"33","author":"Kan","year":"2024","journal-title":"Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.cca.2026.121072_bb0205","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaad.2024.02.052","article-title":"Autoimmune blistering disorders and cardiovascular risks: a population-based cohort study","volume":"91","author":"Bonnesen","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"issue":"6","key":"10.1016\/j.cca.2026.121072_bb0210","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/rheumatology\/kez456","article-title":"Outcomes of acute cardiovascular events in rheumatoid arthritis and systemic lupus erythematosus: a population-based study","volume":"59","author":"Lai","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cca.2026.121072_bb0215","doi-asserted-by":"crossref","first-page":"1215907","DOI":"10.3389\/fcvm.2023.1215907","article-title":"Cardiac magnetic resonance assessment of cardiac involvement in autoimmune diseases","volume":"10","author":"Gulhane","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"issue":"10","key":"10.1016\/j.cca.2026.121072_bb0220","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/CIRCULATIONAHA.110.986372","article-title":"Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis: implications for the diagnosis, therapy, and prognosis of pericarditis","volume":"123","author":"Imazio","year":"2011","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.cca.2026.121072_bb0225","article-title":"Cardiovascular complications in systemic lupus erythematosus","volume":"14","author":"Alghareeb","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.cca.2026.121072_bb0230","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/rai2.70040","article-title":"Cardiac disease in systemic sclerosis: integrating pathobiology with clinical management","volume":"6","author":"Sutanto","year":"2026","journal-title":"Rheumatol Autoimmun"},{"issue":"11","key":"10.1016\/j.cca.2026.121072_bb0235","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1515\/cclm-2016-0062","article-title":"Distribution of soluble suppression of tumorigenicity 2 (sST2), N-terminal pro-brain natriuretic peptide (NT-proBNP), high sensitive troponin I and high-sensitive troponin T in umbilical cord blood","volume":"54","author":"Kim","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"issue":"7","key":"10.1016\/j.cca.2026.121072_bb0240","article-title":"Plasma soluble ST2 as a prognostic biomarker for cardiovascular events and mortality in COVID-19 patients","volume":"12","author":"Yan","year":"2025","journal-title":"J. Cardiovasc. Dev. Dis."},{"issue":"1","key":"10.1016\/j.cca.2026.121072_bb0245","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12872-025-04787-5","article-title":"Association between soluble suppression of tumorigenicity 2 and risk and severity of coronary artery disease: a case control study","volume":"25","author":"Zhang","year":"2025","journal-title":"BMC Cardiovasc. Disord."},{"issue":"17","key":"10.1016\/j.cca.2026.121072_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179598","article-title":"Soluble ST2 as a potential biomarker for abdominal aortic aneurysms\u2014a single-center retrospective cohort study","volume":"23","author":"Klopf","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2026.121072_bb0255","doi-asserted-by":"crossref","first-page":"111037","DOI":"10.1016\/j.clinbiochem.2025.111037","article-title":"Assessment of serum sST2 for cardiac involvement in idiopathic inflammatory myopathies","volume":"1","author":"Li","year":"2025","journal-title":"Clinical Biochemistry"},{"issue":"10","key":"10.1016\/j.cca.2026.121072_bb0260","doi-asserted-by":"crossref","DOI":"10.17219\/acem\/126049","article-title":"Clinical value of soluble ST2 in cardiology","volume":"29","author":"Dudek","year":"2020","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.cca.2026.121072_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1007450","article-title":"Growth stimulation expressed gene 2 (ST2): clinical research and application in the cardiovascular related diseases","volume":"9","author":"Chen","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"2","key":"10.1016\/j.cca.2026.121072_bb0270","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/rheumatology\/keaa270","article-title":"Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular risk","volume":"60","author":"Wienke","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cca.2026.121072_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2018.01.022","article-title":"Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis","volume":"270","author":"Wigren","year":"2018","journal-title":"Atherosclerosis"},{"issue":"17","key":"10.1016\/j.cca.2026.121072_bb0280","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14175955","article-title":"Assessment of serum endocan levels and their associations with arterial stiffness parameters in young patients with systemic lupus erythematosus","volume":"14","author":"Di\u00f3szegi","year":"2025","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.cca.2026.121072_bb0285","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2024-001423","article-title":"Visceral fat, cardiovascular risk factors and quality of life in lupus activity categorized via complement C3","volume":"12","author":"Mart\u00ednez-Urbistondo","year":"2025","journal-title":"Lupus Sci. Med."},{"issue":"18","key":"10.1016\/j.cca.2026.121072_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25189910","article-title":"Enhanced association of novel cardiovascular biomarkers fetuin-a and catestatin with serological and inflammatory markers in rheumatoid arthritis patients","volume":"25","author":"P\u00e0mies","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cca.2026.121072_bb0295","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95234-w","article-title":"Plasma expression of microRNA-425-5p and microRNA-451a as biomarkers of cardiovascular disease in rheumatoid arthritis patients","volume":"11","author":"Taverner","year":"2021","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.cca.2026.121072_bb0300","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1007\/s12011-024-04434-8","article-title":"Serum levels of trace elements (Magnesium, Iron, Zinc, Selenium, and Strontium) are differentially associated with surrogate markers of cardiovascular disease risk in patients with rheumatoid arthritis","volume":"203","author":"Vera","year":"2025","journal-title":"Biol. Trace Elem. Res."},{"issue":"2","key":"10.1016\/j.cca.2026.121072_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12020273","article-title":"Analysis of potential vitamin D molecule biomarkers: association of Calcitriol and its Hydroxylation Efficiency Ratio with cardiovascular disease risk in rheumatoid arthritis patients","volume":"12","author":"Rivera-Escoto","year":"2024","journal-title":"Biomedicines"},{"issue":"10","key":"10.1016\/j.cca.2026.121072_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26104527","article-title":"Metabolic alterations in Colombian women with rheumatoid arthritis and systemic lupus erythematosus reveal potential lipid biomarkers associated with inflammation and cardiovascular risk","volume":"26","author":"Duarte-Delgado","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cca.2026.121072_bb0315","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/ced.14425","article-title":"Evaluation of serum cardiac troponin I and N-terminal pro-B-type natriuretic peptide levels in patients with alopecia areata","volume":"46","author":"El-Sayed Mahmoud Marie","year":"2021","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.cca.2026.121072_bb0320","first-page":"1","article-title":"A five-year risk prediction model of cardiovascular disease in individuals with bipolar disorder: a nationwide register study from Sweden","author":"Dobrosavljevic","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.cca.2026.121072_bb0325","doi-asserted-by":"crossref","first-page":"152468","DOI":"10.1016\/j.semarthrit.2024.152468","article-title":"Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus","volume":"67","author":"Choi","year":"2024","journal-title":"InSeminars in arthritis and rheumatism"},{"issue":"10","key":"10.1016\/j.cca.2026.121072_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9103107","article-title":"Growth differentiation factor-15 as a potent predictor of long-term mortality among subjects with osteoarthritis","volume":"9","author":"Arnold","year":"2020","journal-title":"J. Clin. Med."},{"issue":"8","key":"10.1016\/j.cca.2026.121072_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9082472","article-title":"GlycA levels during the earliest stages of rheumatoid arthritis: potential use as a biomarker of subclinical cardiovascular disease","volume":"9","author":"Rodr\u00edguez-Carrio","year":"2020","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.cca.2026.121072_bb0340","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s10067-022-06122-1","article-title":"Systemic inflammation response index (SIRI) as a novel biomarker in patients with rheumatoid arthritis: a multicenter retrospective study","volume":"41","author":"Xu","year":"2022","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.cca.2026.121072_bb0345","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1161\/CIRCGENETICS.114.000216","article-title":"Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics","volume":"8","author":"Soininen","year":"2015","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"16","key":"10.1016\/j.cca.2026.121072_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11164841","article-title":"Is the calcium score useful for rheumatoid arthritis patients at low or intermediate cardiovascular risk?","volume":"11","author":"Jesson","year":"2022","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.cca.2026.121072_bb0355","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26073071","article-title":"Chronic inflammatory diseases and cardiovascular risk: current insights and future strategies for optimal management","volume":"26","author":"Cacciatore","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2026.121072_bb0360","series-title":"Case-Based Atlas of Cardiovascular Magnetic Resonance","first-page":"205","article-title":"Myocarditis and inflammatory cardiomyopathies","author":"Camastra","year":"2023"},{"key":"10.1016\/j.cca.2026.121072_bb0365","article-title":"Old and new biomarkers associated with endothelial dysfunction in chronic hyperglycemia","volume":"2021","author":"MPA","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"7","key":"10.1016\/j.cca.2026.121072_bb0370","doi-asserted-by":"crossref","first-page":"11324","DOI":"10.3390\/ijms150711324","article-title":"Endothelial dysfunction in chronic inflammatory diseases","volume":"15","author":"Steyers","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.cca.2026.121072_bb0375","doi-asserted-by":"crossref","first-page":"R634","DOI":"10.1186\/ar1717","article-title":"Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis","volume":"7","author":"Dessein","year":"2005","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.cca.2026.121072_bb0380","doi-asserted-by":"crossref","DOI":"10.3390\/jpm16010007","article-title":"Endocan as a novel biomarker for endothelial dysfunction and cardiovascular prognosis in ST-elevation myocardial infarction: a contemporary literature review","volume":"16","author":"Khatri","year":"2025","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.cca.2026.121072_bb0385","doi-asserted-by":"crossref","first-page":"120966","DOI":"10.1016\/j.cca.2026.120966","article-title":"Beyond cholesterol: targeting inflammatory biomarkers in cardiovascular disease","volume":"9","author":"Abuhassan","year":"2026","journal-title":"Clinica Chimica Acta."},{"issue":"11","key":"10.1016\/j.cca.2026.121072_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108133","article-title":"An interleukin 6 responsive plasma cell signature is associated with disease progression in systemic sclerosis interstitial lung disease","volume":"26","author":"Jia","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.cca.2026.121072_bb0395","article-title":"Longitudinal monitoring of IL-6 and CRP in inflammatory bowel disease using IBD-AWARE","volume":"16","author":"Hirten","year":"2024","journal-title":"Biosens. Bioelectron. X"},{"key":"10.1016\/j.cca.2026.121072_bb0400","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.2147\/JIR.S276986","article-title":"Monitoring and managing cardiovascular risk in immune mediated inflammatory diseases","author":"Anyfanti","year":"2021","journal-title":"J. Inflamm. Res."},{"issue":"18","key":"10.1016\/j.cca.2026.121072_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26188921","article-title":"Comprehensive profiling of cytokines and growth factors: pathogenic roles and clinical applications in autoimmune diseases","volume":"26","author":"Donniacuo","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2026.121072_bb0410","article-title":"Immune cell crosstalk between ANCA-associated vasculitis and IgG4-related disease: an unresolved pathogenic link","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cca.2026.121072_bb0415","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/ijms23010387","article-title":"B lineage cells in ANCA-associated vasculitis","volume":"23","author":"Merino-Vico","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.cca.2026.121072_bb0420","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1093\/ehjci\/jeac134","article-title":"Cardiovascular magnetic resonance in autoimmune rheumatic diseases: a clinical consensus document by the European Association of Cardiovascular Imaging","volume":"23","author":"Mavrogeni","year":"2022","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"1","key":"10.1016\/j.cca.2026.121072_bb0425","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/1871529X18666180508111353","article-title":"Recent advances in understanding the pathogenesis of cardiovascular diseases and development of treatment modalities","volume":"19","author":"Mittal","year":"2019","journal-title":"Cardiovasc. Hematol. Disord. Drug Targets"},{"key":"10.1016\/j.cca.2026.121072_bb0430","unstructured":"Shyam-Sundar V, Slabaugh G, Mohiddin S, Petersen S, Aung N. 6-022 Using serum biomarkers to predict T1 and T2 on cardiac MRI in patients presenting with acute myocarditis."},{"issue":"4","key":"10.1016\/j.cca.2026.121072_bb0435","article-title":"Clinical evidence of wearable-derived heart rate variability for detecting systemic inflammation: a systematic review","volume":"16","author":"Siswishanto","year":"2026","journal-title":"Diagnostics (Basel)."},{"issue":"1","key":"10.1016\/j.cca.2026.121072_bb0440","doi-asserted-by":"crossref","DOI":"10.1038\/s41746-025-01939-x","article-title":"Systematic review: digital biomarkers of fatigue in chronic diseases","volume":"8","author":"Aboagye","year":"2025","journal-title":"npj Digit. Med."},{"issue":"6","key":"10.1016\/j.cca.2026.121072_bb0445","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s11897-024-00683-9","article-title":"Emerging biomarkers in cardiac sarcoidosis and other inflammatory cardiomyopathies","volume":"21","author":"Roumi","year":"2024","journal-title":"Curr. Heart Fail. Rep."},{"issue":"4","key":"10.1016\/j.cca.2026.121072_bb0450","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s12551-022-00990-2","article-title":"Cardiovascular biomarkers in body fluids: Progress and prospects in optical sensors","volume":"14","author":"John","year":"2022","journal-title":"Biophys. Rev."},{"issue":"2","key":"10.1016\/j.cca.2026.121072_bb0455","article-title":"Innovations in cardiovascular disease prevention: from biomarkers to digital health applications","volume":"23","author":"A","year":"2025","journal-title":"Bio-Res."},{"issue":"2","key":"10.1016\/j.cca.2026.121072_bb0460","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.ijcard.2013.07.046","article-title":"Serial measurements of cardiac troponin I in patients with myasthenia gravis-related cardiomyopathy","volume":"168","author":"Kumagai","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"3\u20134","key":"10.1016\/j.cca.2026.121072_bb0465","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jaut.2009.09.006","article-title":"Clustering and commonalities among autoimmune diseases","volume":"33","author":"Mackay","year":"2009","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cca.2026.121072_bb0470","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.00088","article-title":"The evolving understanding and approach to residual cardiovascular risk management","volume":"7","author":"Dhindsa","year":"2020","journal-title":"Front. Cardiovasc. Med."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126002548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126002548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:27:37Z","timestamp":1783643257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126002548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":94,"alternative-id":["S0009898126002548"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.121072","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation and cardiovascular risk in autoimmune diseases: Mechanisms, biomarkers, and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.121072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"121072"}}